恶性黑色素瘤患者伊匹木单抗诱导的机化性肺炎在18F-FDG PET/CT上的表现
一例60岁女性阴道恶性黑色素瘤伴腹股沟淋巴结转移患者,在接受伊匹木单抗免疫治疗后行18F-FDG PET/CT再分期,显示双肺多发放大磨玻璃影伴环形高代谢(反晕征),患者无症状;停用伊匹木单抗后3个月随访PET/CT示肺部病灶自发完全消退,支持伊匹木单抗诱导的机化性肺炎诊断。
要点
- 伊匹木单抗治疗后的患者行18F-FDG PET/CT再分期时,双肺多发放大磨玻璃影伴环形FDG摄取(反晕征)需警惕机化性肺炎。
- 患者影像学异常时无症状,停用伊匹木单抗后3个月随访PET/CT示肺部病灶自发完全消退。
- 影像学表现结合用药史及随访转归支持伊匹木单抗诱导的机化性肺炎诊断。
核心结论
- 停用伊匹木单抗后3个月随访PET/CT示肺部病灶自发完全消退,支持伊匹木单抗诱导的机化性肺炎诊断。
研究设计与样本
- 一例60岁女性阴道恶性黑色素瘤伴腹股沟淋巴结转移患者的病例报告,在伊匹木单抗免疫治疗后行18F-FDG PET/CT再分期。
主要发现
- PET/CT示双肺多发放大磨玻璃影,FDG摄取轻度增高。
- 每个肺部病灶内可见环形摄取,定位于CT上的高衰减边缘,中心为磨玻璃样低密度区,符合「反晕征」。
- 影像检查时患者无症状。
- 停用伊匹木单抗后3个月随访PET/CT示肺部病灶自发完全消退。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 60-year-old woman with history of vaginal malignant melanoma and inguinal nodal metastases underwent F-FDG PET/CT for restaging following ipilimumab (Yervoy) immunotherapy, a Food and Drug Administration-approved human monoclonal antibody targeting cytotoxic T-lymphocyte-associated antigen 4. PET/CT demonstrated mildly FDG-avid multifocal enlarging bilateral lung opacities. Within each lung lesion, there was circumferential uptake localizing to a high-attenuation rim with a photopenic ground-glass center on CT, consistent with "reversed halo sign." Patient was asymptomatic at the time of imaging. Ipilimumab was discontinued, and 3-month follow-up PET/CT revealed spontaneous complete resolution of the lung lesions, supporting the diagnosis of ipilimumab-induced organizing pneumonia.
引用
- Raad RA, Kannan R, Madden K, et al. Ipilimumab-Induced Organizing Pneumonia on 18F-FDG PET/CT in a Patient With Malignant Melanoma. Clin Nucl Med. 2017. PMID: 28481788. doi:10.1097/RLU.0000000000001673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。